Thanks for downloading and welcome to Take Orally, the emergency medicine podcast recorded at Dream Queen's Medical Centre at Nottingham. In this episode we'll be discussing the ED pharmacist. As ever, all guidelines are correct for Nottingham University Hospitals NHS Trust. All information given is correct at the time of recording. All views and opinions are the speaker's own.
Hello once again, welcome back to Take Aurelie. My name is Jamie, one of the teaching fellows in emergency medicine, and I'm delighted to be joined by my colleague, ED pharmacist, Canal Goughill. Hello, Canal. Good morning, Jamie. Thanks for being here. Appreciate it. Thanks for coming along, Canal. We've asked Canal to come down because I think it's fair to say this year, Canal, I've noticed on Twitter and in conferences there's quite a lot of interest in the role of pharmacists within the emergency department. How long have you been in post now at the Queen's Medical Centre ED? So in post in ED has been since April 2016, so we're looking at getting on towards 18 months now in ED.
pilot phase was one year which ended sort of April of this year results were encouraging enough for a department to fund us to continue so we've now got permanent role shop floor pharmacist in the department so this podcast we're going to just look really about how that came about looking at the background of a pharmacist, and then how your role has developed whilst you've been in the emergency department. So first off, I mean, speaking for myself, I'm not entirely aware of what the training of pharmacists goes through, so do you mind just letting us know what it's like over here in the UK, how long the course is at uni, etc. Yeah, absolutely. I mean, so pharmacy, allied medical professional course, so you do your GCSEs and A-levels as normal. The degree programme is a four-year integrated master's, so three years of taught at sort of a bachelor's level, and those three years sort of incorporate your basic human physiology, your cell biology.
clinical pharmacology and medicinal chemistry, so it's quite theoretically heavy. We do a bit of clinical practice as well, so there's competencies, clinical practice, and then the fourth year is taught as a master's year, do your dissertation, do a little bit more in terms of research methods and things like that. After four years finish, you have your master's under your belt, your M-Pharm, and you do one year of supervised practice. Some people go and do that in community, in your boots or what have you. Some people are doing it in hospitals. And once you've done that one year of supervised practice...
demonstrate your competencies and take a big pretty tricky exam at the end of it and if you pass all that you get on the register and you're armed with your green pen. Why is it a green pen? I really don't know I think it's just a historical thing. Some trusts use pen apple but we've always used green. Okay so whilst at uni how much time with a patient do you get in pharmacy? So to be honest it depends it varies on course to course there's about 20-25 odd schools of pharmacy.
It varies massively. So my course, I was at the University of Hertfordshire, we have quite a lot of patient-facing roles. So even from the first year, we had placements out in community, placements out in hospitals. But it does vary on place to place. I wouldn't say that compared to, say, medicine, or more of a patient-facing role, that you have that much. But we'd say go for a couple of weeks a year on placements to get competencies done and that sort of thing. So it's more of a theoretical kind of health profession, so to speak.
Okay, so think about yourself specifically then. Before you came to the emergency department, where was your background? Where would you work? So me specifically, whilst I was training up, whilst I was doing my master's in pharmacy, I worked in community. So I was sort of a local chemist kind of boy, so we dealt with a lot of minor elements, dispensing prescriptions, a lot of the sort of primary care type stuff. For me, once I finished the master's, I didn't really fancy continuing that. I wanted to get more into the real clinical stuff. So I went and did my training year, that fifth year, where you have to have a supervised practice. I did that in London at UCLH.
It was a really good place, big teaching hospital, so I learned a lot there. And then decided to continue in hospital practice, try and do a little bit more clinical things. So I came and did my basic grade here in Nottingham. So that was a two-year residency where we do a clinical diploma in hospital pharmacy practice, learn about the basics of cardiology, diabetes, orthopedics, neurology, your basic areas of medicine. So we get very familiar with the drugs that we use in that. After the two years, we're competent as being specialists in those areas of medicine. Not specialists per se, but very good at those areas of medicine. And then typically we pursue our own particular specialist interest. And so for me, it's ended up being emergency medicine.
So then how did it come about that you came down to us? Because from my point of view, one day you weren't there and then suddenly you were. You were going, hello, I'm your unique pharmacist. So how did that come about? It was all a bit of a, it was all quite fast to be honest. So I was working over in hyper-acute stroke before I came up. There was a big pilot that was done in 2015 in the East and West Midlands around, it was run by Health Education England where...
There was a big drive to try and get pharmacists tooled up with extra skills to be able to see some of the minor's cases to try and take the strain off A&E departments because it was identified as a priority. We don't necessarily have as many doctors as we want to do. So off the back of that, there was some figures saying that pharmacists could manage anywhere between 5% and 30% of the patients that come through A&Es. So quite a big variance, but it depends on how skilled up pharmacists are. So the idea was that somewhere around 30% is if you have pharmacists who have done an advanced practitioner course in a similar way that our nurses do here.
So off the back of that page, Health Education England gave us a pot of money for a year's funding to explore that role. That was the role that I went for because it was very interesting to me in terms of skilling up and being able to see and treat patients. And that's how I basically got the job. And there was a push for funding and so we basically had to start on the day, otherwise we would have lost funding in April. So it literally was the Friday I finished in hyper-acute stroke and the Monday I showed up in A&E.
What were your preconceptions then? That weekend, you think, I finished stroke, I'm now coming into the emergency department. What were your preconceptions? To be honest, I really didn't know. So I'm one of these weird people that I've never actually been to an A&E in my life. I've never broken a bone or got cap or whatever. So I've never been to an A&E. So I knew it was a busy area, but I think in my head.
I was thinking it was much more like an AMRU admissions type area because obviously I've worked on admissions wards and things like that. I assumed it was this sort of situation. I'd never physically been down to anything before. So I showed up on the first day because obviously I didn't have any real training and I needed to get my orientation in the department and it was a particularly busy day where we didn't have flow, whatever that meant. So I went to our majors department and it was just like a war zone. I'd never seen anything like it. I really thought what I was getting myself into. There was maybe 15 people in the middle of our majors area and then all the cubicles filled up and then there was doctors and nurses running around.
went to the resus area and there was a car crash with three people or major traumas called in with 40 people in resus and I thought I don't know where to start here but that being said it was scary but I thought wow this is somewhere that I can't believe there hasn't been a pharmacist before and you can see very quickly just by picking up some charts and reading some of the notes that could really get stuck in and help out as much as I can. So what were your priorities then when you came in? So you started, you're in the emergency department, you think, gosh, what have I got myself into? You're looking at the charts. Where did you think you, where was your priority when you started? Yeah, absolutely. I mean, so the funding, as I say, came from health education and about developing an advanced practitioner role. So really speaking, my remit was to go in and find the areas that you can actually take on some of the responsibility. Now, the invariable problem with that was that I was generally quite a junior pharmacist when I first started. I had been qualified for about two years. I didn't really have any of that extra training. I was due to go and start it.
So when I came down, there was probably a lag period of three or four months where I didn't have the skills to be able to see and treat patients, but I was there and I had to do something. So pretty much what I thought I'd do was do the traditional ward role of a clinical pharmacist, which is go in, review the drug charts, get very accurate primary drug histories, and try and find out if they're having adverse effects, and try and streamline their journey from ED to the ward and try and make it as safe as possible. So you're trying to see everyone? Well, it would have been impossible, considering we'd get 500 odd patients a day. Originally, I went in and quite simply all I did was anybody that was tagged for an inpatient stay, tried to get them a drug history done, tried to get medicines reconciled for them, particularly the higher risk type people. Now, pretty evidently, early on, when you've got 20 to 30 people waiting for beds at any one point, you can't be effective in that role. So the service developed over the first three to six months where we stopped trying to see everybody because quite a lot of them were what we call medically low risk in terms of not being on any particularly high risk therapies, not needing a real pharmacist input to the patients that actually needed a lot more.
a lot more input medically, medication-wise. So people on insulin, Parkinson's, anti-epileptics, people that have sepsis, people that need repeat antibiotics and tweaking of their fluids with lots of comorbidities. They were the things that we could really offer things for. And so the service kind of developed where we were picking up these patients, identifying them, seeing them, then making recommendations to the clinicians that were looking after them in Haiti. Pretty much just trying to safeguard them whilst they're in the department and then improve their journey up onto the ward.
So what sort of recommendations do you think you make then, just off the top of your head? So there was lots. I mean, a lot of them is around critical drugs. So when I talk about critical drugs, as I said before, I talk about pre-existing therapies that are on. So insulins and anti-epileptics and Parkinson's drugs and things like that. The simplest intervention I make is just ask them to be prescribed, which prevents them from deteriorating whilst they're in the department, prevents them from having another problem, so to speak. You have a patient that comes in with a raging chest sepsis who's also a type 1 diabetic, for example. You can treat their cat beautifully with antibiotics and fluids and get your lactate, etc.
But if you don't give them their insulin and put a plan in place for that, they'll deteriorate irrespective. So it's very much looking at the background and making sure we're keeping them ticking over in terms of their comorbidities. So that would be a key one, just getting their regular therapies continued as appropriate. Another thing would be what my role has kind of developed as is almost being the expert in looking at whether this presenting complaint could be due to an adverse effect of the medicine. So it's been in the news quite recently. I think Jeremy Hunt's been saying that somewhere between 5% and 8% of all cases coming into A&E are medication-related. I'm not sure whether that's true, but there certainly are quite a few.
Things like a patient comes in confused and hyponadremic, and we do them a full workup for why this might be. And it's very easy for me to look at their medication regime and say they're on several drugs that stack that cause hyponadremia. If you think about reviewing them, you'll correct the problem. So to give you some sort of an explanation, a diagnostic reason for their presenting complaint from a medicine's point of view, to sort of have a drug head-on about everything. So what are your shifts then? So how long is your working day? What patterns do you do? And how does your normal, as much as a normal working day can be, what do you do? Yeah, so absolutely. So, I mean, it's changed over time. So originally, I used to start at 7.30 in the morning when the doctor's handover was, so I could be part of the team and the handover for that, can feed back any particular medication issues on the day. And I'd work through to about 3 or 4 p.m. reviewing patients. Right now, we've only got funding for myself, so it's very much 37.5 hours a week, and we're trying to improve that because there's more scope for it.
doing more services down in ED. A typical day is you come in at 7.30, I would review every single patient, and when I say review, I'd look at patients waiting in the department, get a primary drug history for them, this might not mean recording it, but looking at their regime, reading through the notes, so finding out what's going on with them, and then stratifying them in terms of a risk whilst they're waiting in the department. High-risk people would be patients that I think have had a medication-related admission, so the reason they're here is something to do with their medicines. Then being on a time-critical drug, so something that if they missed or wasn't looked at meant they could deteriorate within the department. Patients generally have been diagnosed with AKIs or have chronic kidney disease because we quite often have to change our normal therapies for these kind of patients. And then generally just cases that are at my discretion that I can look at. So, for example, patients that have come in with falls or collapses that are on really big polypharmacy regimes, things that are quite often inappropriate. So these things that we can tweak before we send them off home with their CT head being clean. So we make a list of these patients and quite simply I prioritise them for how.
how quickly I thought I needed to see them. I'd see them, get a drug history done, make my recommendations to the clinician that's looking after them, and then safeguard them, put them a medication plan in place whilst they're in an A&E, which hopefully helps them once they get onto the base ward as well. And when you say you take a drug history, do you see the patient, or do you use a summary care record? So quite often I might use a summary care record as my initial screening tool. Quite often I'll use previous discharges and a combination of that and the medical clerking. I mean, from reading a case and looking at the background, I can quite often get a very quick sense of what somebody might be on.
Parkinson's case, it's very likely that they're going to be on an anti-Parkinson's drug. If they're documented in their history as having AF, for example, I know that there's a high risk that they could be on anticoagulant, so I might need to dig deeper and find if they're on anticoagulant, which often changes the need for a CT head, for example. So there's lots of different little ways that I can get a drug history, but whenever I can, I will always try and see the patient to be able to confirm that drug history, find out what they're taking. But obviously there's a lot of patients to see, so you have to use whatever means you can. And then I suppose you can also liaise with the, if you know where your patient is going, you can liaise with the pharmacist on the ward there as well? Yeah, it's very much become quite a big part of it now. So these particularly high-risk patients, and when I say high-risk, there's lots of different levels of high-risk, but people where we haven't necessarily been able to, where I haven't necessarily been able to action everything I wanted to action in A&E before they've been moved to a base ward, but I have quite a lot of information about the case at that point, I can directly hand them over to our ward teams.
pharmacist ward teams on base ward and they can follow up and be able to do the investigations that I don't have the time to do at A&E. So there's a good continuing flow of information between the two departments. I suppose you can also offer, and I know you have for me myself, if a patient's condition means that they can't take an oral medication, you are able to offer alternative, say they're on a regular... anti-epileptic, anti-Parkinson. That's all sort of advice I've heard you give. Yeah, I mean, that's very much our sort of specialist role in terms of substituting therapies and manipulating formulations. I mean, you can't do it for all drugs. I mean, a classic example would be when we have a patient with Parkinson's disease that's unwell and we can't safely allow them to swallow their tablets. We can sometimes convert to a patch, which will give us some time. We can think about converting, well, we can think about putting an NG tube down. As you say, epileptic tablets, we can switch to IVs, we can switch to suppositories. Sometimes we can change the therapy altogether and go with a completely different approach. It's all a case-by-case basis.
Having a point of contact, which is what I found is probably the most important thing. Having a pharmacist on the shop floor, visible and readily available. I've found that clinicians will use that service more than if it's a wizardy type service where it's a contact number that you need for advice. And we've got evidence to show that. I mean, when we've looked at the, before I started in A&E, that's the kind of service we had where we had a pharmacist who was responsible for A&E, but it wasn't a shop floor service. So whenever they were needed, they would rang, they would come down, they would offer the advice, which is fine. So when we've looked at the number of patients and number of interventions we've made whilst we've been on the shop floor versus that older service, it's almost 10 times as many interventions and uses.
even though the queries are very similar. So it just goes to show the physical presence is much more well utilised and there's actually a lot of literature about it. And developing a personal relationship as well. Yeah, the rapport is really important because at the end of the day I was originally a stranger walking into A&E, you don't know much about my background, you don't know much about my training. So it's more than reasonable for A&E consultants and registrars who have been doing the job for a long time to be wondering why I'm down there telling you what to prescribe and what to do there. So I think over the time period just the trust in being able to...
recommend things and uptake recommendations is developed as well, which is actually a really important part of it. Getting new people down is a problem because you have to develop that trust in that report. Because it is a high-risk environment. It's an environment where you're working under time constraints and there's no top-end of patients that you're going to be able to see. So if someone's making a recommendation for you, you have to be happy and have the trust that that's an appropriate thing to do. I often hear this phenomenon, I'm not sure how true it is, but that there are some people...
A&E is a very chalk and cheese, black and white place. You either like it and fit into it and it's the sort of place that you can work or it's somewhere that you absolutely hate and people experience it and they move away. Do you think the same might be said for pharmacists? Oh yeah. So I think pharmacists in general, pharmacists are risk-averse people. The whole idea of the job role of pharmacists working in hospital practice is to mitigate risk. And the problem with A&E is you're working in possibly the most high-risk environment.
in the hospital as far as I'm concerned you're dealing with situations where you have limited amounts of information you're under time pressures and you have limited resources available so I think for me that's what I find that the skills that I have as a pharmacist in terms of being able to very quickly look at a medication regime find out if there's an adverse effect find out if anything we're going to start in terms of treatment for this patient is going to interact or give us further problems and put a plan in place with limited information is something I really thrive on. I really, really enjoy it. I think some of my colleagues might struggle with that. They want a lot more information before basing a recommendation on it, which is always going to be a problem because you've got limited information. Generally, there aren't that many pharmacists actively working clinically in A&Es across the country at the moment. It's a growing thing. So I think at some point it's probably going to become a speciality. Clinical pharmacist in emergency medicine will become a speciality unto itself. And it's something that we're sort of collecting evidence on and we have to come up with guidelines in terms of...
making particular recommendations in particular scenarios when we don't have the amount of information. So it's a difficult one. For me, I really thrive on it, and I think it's probably where you can make the biggest impact. Excellent. So you mentioned already that you've collected some evidence about the improvements that the service has brought in. Have you got any other examples of any data? Yeah, I mean, we've collected a lot of data. So over that pilot period, as I've kind of alluded to, the funding we had was for an advanced practice role. That very much morphed over that year to a clinical role. And we obviously only had the money for one year, so we had to prove our case for continuing it. So what we did was we collected pretty much every single intervention we made and every single patient we reviewed and saw over time. We made somewhere in the region of 1,500 to 2,000 clinical...
interventions or recommendations in patients care over the course of reviewing about 8 to 12,000 cases. So a lot of cases were reviewed over that time period. When we then looked at these very carefully in terms of the severity and the importance of the interventions we were making, and we compared that to what pharmacists usually do in the trust, we found that the severity of the contributions were about generally four times more serious or severe than the typical contributions a pharmacist would make on a ward level. So when I say serious or severe, I mean if these interventions weren't made, they have the potential to cause significant morbidity or occasionally even mortality to a patient. So an example would be, for example, omitting a whole day's worth of anti- Parkinson's medications, which has the potential to cause quite serious morbidity. When I talk about mortality, trying to give...
tass us into a patient with a pen allergy, which unfortunately does happen. So lots and lots of interventions that's improved that quality. The other thing we've looked at is efficiency in helping frontline ED clinicians. So some of the things I do are taking the pressure off ED clinicians. So the classic being quite complicated medication information inquiries. So as we've said before, changing an anti-epileptic therapy to an IV or switching it over.
A junior ED clinician, it could take them quite a considerable amount of time to look into the evidence, to look into the resources and make a recommendation. They then probably take that to a registrar or a consultant who wants to agree with their plan, and then they've got to implement the change. There's now a point of contact with me. I'll give you a good example. There's a patient on Valproate who's nil by mouth because their GCS is low, but we obviously need to get into them. I'll give them a straight IV switch, give them a new regime. I'm the expert in that field, so they feel happy to prescribe it on my recommendation. It takes the pressure off the regs and the consultants, and the patient gets the drugs quicker.
So we found somewhere in the region of 200 hours worth of ED clinician decision-maker time saved by that. So a decent amount of efficiency savings there. Similarly, we looked at nurses, how we helped our nursing colleagues. It was one of the things when I first came to the department that the ED nurses are really running around struggling with medications. First thing we did was did a big overhaul of all the stock we keep in ED to make sure we've got the right things for these nursing staff when they need it, where they need it. So putting the correct drugs in place. And then obviously we've got situations where patients are coming in who are on very peculiar therapies or things that we might not necessarily have easy access to. Very particular insulin regimes, very particular cardiovascular regimes. But again, we need to think about continuing to prevent them from deteriorating. We don't want nurses running to other wards or to other areas to try and obtain these. This is just causing a delay. It's not a nurse's job, really speaking.
Medication supply is absolutely a clinical pharmacy job. So what we're able to do is a nurse is very quickly able to approach me and say, this is a drug that's been prescribed. I don't think we've got it here. Can we get hold of it? I can say to them, yes, we can source that. And the pharmacy then take on the responsibility of sourcing it, getting it down, and the nurses just administer it, which is the way the chain of command should be, so to speak. And that being said, just as much, we can make a clinical decision and say, actually, I know these have been prescribed, but this patient's going to the ward in half an hour, and there'd be very little harm for it to be handed over onto the ward.
So looking at some of the nursing efficiency savings, again, somewhere between 200 and 250 hours of nursing time saved, which you can double up if you think about it, because if you haven't got a nurse doing what they need to be doing in the department, it's going to take someone else to do it. So nursing colleagues have really enjoyed the service as well. And when we got a bit of feedback from all the staff, so unanimously from the administrators, the flow progress chasers, consultants, regs, junior doctors, nurses, they found the clinical pharmacy service in ED to be massively beneficial. So putting it all together and auditing and putting it into a cost saving, we have some equations that we use in pharmacy where we plug interventions and efficiency savings into cost savings. And we estimate in that year period, we've saved somewhere in the region of three quarters of a million pounds to 1.3 million pounds. Now that's in terms of prevention of adverse effects.
bringing down bed waiting days, let them inpatient stay because of preventing these, nursing time saved, ED, clinician time saved. It's all potential savings, so it's not like we've actually been seeing patients and taking the pressure off that way. But it gives us an illustration of how much we've been impacting the team from a financial point of view, which is obviously always the difficult thing in making a case about a full-time service. Excellent. So where do you see it going? If you look into your crystal ball, you've mentioned you think it'll be a subspecialty. Do you see this contact that you've had, the interest that you've had? Do you think in the future every emergency department will have a 24-7 pharmacist? I think a 24-7 is probably asking a little bit too much for a physical presence. For me, at the moment, we're 18 months in, and we've got one solid permanent pharmacist, 9-5 for a weekday, which isn't bad after 18 months, and we've got a plan for it to continue.
The first step now is to expand that service. So really speaking, when we look at the patient profile that I see, when they come into A&E and the workload, one pharmacist isn't going to be able to cut it, really speaking. The model we're building on is similar to our admissions unit here in Queens. So what we want to do is try to expand the service to a seven-day-a-week service. Saturday and Sunday should be included. There's no real difference between a Saturday and a weekday. You're going to get a similar amount here. So really speaking, 12 hours a day is going to be around about 75% of the people I see.
So we'd be looking at something like an 8-to-8 Monday-to-Sunday service to run every day of the year, which fits in well with what the NHS is trying to get to at the moment. Obviously, when we've put this to some of the senior ED management, some have said, why can't we have a 24-7 service? I think it wouldn't be a bad thing. But I think trying to recruit and try to manage a service that big would be, whether or not then there's another pathway of pharmacists, going back to that original idea of becoming advanced practitioners and actually seeing and treating some of this patient process, such value we've found so far in just traditional clinical pharmacy services.
And then finally, any, obviously a whole podcast hopefully is advisory, but if anybody's listening to this and thinking from another department, another emergency department elsewhere, thinking about bringing in pharmacists, any advice just off the top of your head? Yeah, I mean, I think it's one that we never really fully considered it until we got someone down here. So I'd almost suggest if you've got an ED, most emergency departments in NHS drafts around will have a pharmacist attached to them. Probably not necessarily directly working on the shop floor. But if this is something that's interesting to you, try and make contact with that contact and see if you can organise a pilot, even if it be just for a week, just for working on the shop floor and seeing what can be done. Because that can really whet the appetite for... Forming a business case. Absolutely, absolutely. So there's usually always a point of contact. I would get that involved. I mean, our service here, we've published a couple of papers now and there's some posters that have gone out. So I'd encourage you to have a little look at that and look in more depth at some of the data we've created. And generally just try and... I mean, I've been very lucky here when I've come down. I've worked in particular departments before where...
you're not necessarily as a pharmacist that well welcomed into the team. And for me, the first day I came down and introduced myself to the nurses in charge and the consultants in charge. understood the benefit and were very, very welcoming to me and very accommodating to me. And that really drove me forward in being able to make interventions. So if you are getting pharmacists involved, it's trying to welcome them and trying to make use of what they can do for you as best as you can. Brilliant. And if we can have, I'll put up a link to those papers. Yeah, absolutely. So we'll do that on the Take Orally blog. Thank you so much for coming, Colonel. It's been a pleasure. Thank you so much for working in the emergency department. It's been brilliant. We'll be doing some podcasts in the future looking more at specific therapeutics, but I thought it was important to get this general sort of podcast out there first. But thank you so much. Absolutely. Pleasure.
That was the ED Pharmacist Take Orally podcast. You can find a specific blog and this podcast at takeorally.com. The podcast is also available on SoundCloud and iTunes. You can also find Take Orally on both Facebook and Twitter. For more information about research and education opportunities in acute medicine and emergency medicine and major trauma, you can find NUH Dream on both Facebook and Twitter.